Contineum Therapeutics Inc (CTNM)
NASDAQ
The current CTNM market cap is 371.46M. The company's latest EPS is USD 0.8814 and P/E is 16.35.
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|
USD ($) | |||
Total Revenue | 0 | 0 | 0 |
Operating Income | -9.93M | -10.94M | -12.97M |
Net Income | -8.42M | -9.01M | -10.27M |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Revenue | 50M |
Operating Income | 16.08M |
Net Income | 22.72M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|
USD ($) | |||
Total Assets | 123.56M | 221.36M | 216.03M |
Total Liabilities | 6.57M | 3.85M | 5.81M |
Total Equity | -75.63M | 217.5M | 210.23M |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Assets | 130.39M |
Total Liabilities | 5.7M |
Total Equity | -67.94M |
Market Cap | 371.46M |
Price to Earnings Ratio | 16.35 |
Price to Sales Ratio | 7.43 |
Price to Cash Ratio | 23.92 |
Price to Book Ratio | 2.98 |
Dividend Yield | - |
Shares Outstanding | 25.78M |
Average Volume (1 week) | 286.4k |
Average Volume (1 Month) | 132.4k |
52 Week Change | -0.62% |
52 Week High | 22.00 |
52 Week Low | 12.33 |
Spread (Intraday) | 16.95 (74.64%) |
Company Name | Contineum Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.contineum-tx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.